SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as retail investors weigh the company's aggressive $10.2 billion capital raise to fuel its AI expansion against concerns from prominent investors regarding shareholder dilution. The community is actively debating the stock's future, with many bullish on its cloud and AI growth prospects while others remain wary of regulatory risks and past performance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors eagerly anticipate the 80th clinical event from the REGAL Phase 3 trial, with community sentiment split between high-stakes buyout speculation and heated debates over the trial's validity and potential curative outcomes. The buzz is further intensified by significant institutional accumulation and comparisons to recent oncology vaccine breakthroughs that have historically triggered massive valuation shifts.

TOSHI

TOSHI is trending as the community speculates on a potential short squeeze, fueled by bullish sentiment regarding future exchange listings and hopes that the token will reclaim previous highs. Investors are actively accumulating positions and monitoring order book activity, maintaining a strong conviction in the project's long-term potential despite recent volatility.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant attention after disclosing a major partnership with Google to develop custom AI silicon, a deal that includes a significant warrant agreement. While the stock has seen high volatility, community sentiment is largely centered on whether this strategic move will drive long-term revenue growth or result in shareholder dilution.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending as investors weigh strong earnings and guidance against persistent price action volatility, while the community intensely debates potential buyout scenarios and institutional positioning ahead of upcoming pipeline catalysts.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is trending as investors react to a new $600 million at-the-market equity offering, sparking heated debate between those fearing share dilution and others viewing it as necessary capital to fuel data center demand. While some retail traders are aggressively shorting the stock in anticipation of further price declines, others are treating the dip as a long-term buying opportunity to gain exposure to AI-driven photonics.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

The biotech sector is trending as investors rotate into healthcare, driven by a surge in M&A activity and positive sentiment regarding clinical trial breakthroughs and regulatory catalysts. Community discussion centers on identifying undervalued assets and monitoring institutional accumulation as biotech ETFs reach key technical resistance levels.

Ethena

Ethena is trending as investors focus on its strong institutional backing and the significant accumulation of ENA tokens by StablecoinX, which serves as a public gateway to the ecosystem. The community remains highly bullish, frequently highlighting the project's growth potential and its correlation with broader crypto market movements.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan is trending as community members emphasize its position as a long-term cultural asset, often comparing its memetic significance to the role Bitcoin plays in the broader crypto market. Investors are actively discussing the token's massive supply and specific zero-heavy price structure as a unique opportunity for high-leverage exposure, while highlighting features like blacklisted wallets as a key differentiator for their community-driven model.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending as investors rotate capital into the sector, with market participants closely monitoring potential M&A activity and positive trial data readouts for key constituents. The community is actively debating the risk-reward profiles of small-cap biotech plays and the impact of broader market volatility on the sector's recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xcelerate, Inc. is a medical company, which engages in the provision of acquiring intellectual property technology for medical applications. The company was founded on November 26, 1996 and is headquartered in Mauldin, SC.

Xcelerate Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0102
Prev Close	$0.01
Open	$0.0102
Dividend Yield	0.00%
50-Day Moving Average	$0.0114
Beta	0.04
Avg. Volume	42,325.91
PE Ratio	-1.56

52-Week High	$0.02
52-Week Low	$0.0061
Market Capitalization	$4.26M
EPS (Annual)	-$0.0028
Price to Book	-2.10
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info